Objective: we investigated the association between the peroxisome proliferator-activated receptor (PPAR)-gamma Pro12Ala polymorphism and cognitive decline in older adults. Methods: participants from a population-based cohort of older Hispanic and non-Hispanic white adults (n = 492) were administered the Mini Mental State Examination (MMSE), a multi-domain cognitive screening tool, and the Behavioral Dyscontrol Scale (BDS), a measure of executive cognitive function, at baseline and at follow-up, an average of 22 months later. Multiple linear regression was used to investigate the association between the two cognitive test scores and the Pro12Ala polymorphism. Results: at baseline, presence of the Ala12 allele was not significantly associated with MMSE score (P = 0.62) nor with BDS score (P = 0.85). Heterogeneity was present for cognitive decline as measured by the MMSE among ethnic, sex and Ala12 allele status (P = 0.04 for three-way interaction term). Stratification by the cross-classification of sex and ethnicity revealed significantly greater declines in MMSE score among male Hispanic carriers of the Ala12 allele compared to male Hispanic non-carriers (decline = 4.0 versus 1.6 points; P = 0.02). A significant difference in decline between Ala12 carriers and non-carriers was not present among the other sex/ethnic groups. Conclusions: carriers of the PPAR-γ Ala12 allele showed greater cognitive decline compared to non-carriers as detected by the MMSE but the risk varied across sex and ethnic groups. Male Ala12 carriers of Hispanic origin may be a high-risk group for cognitive decline.
Introduction
Recent developments linking metabolic dysfunction to lateonset Alzheimer's disease (AD) have led to the investigation of genes involved in lipid and glucose metabolism as potential susceptibility loci for cognitive decline and dementia [1] . The peroxisome proliferator-activated receptor gamma (PPAR-γ) gene plays a key role in lipid metabolism and insulin sensitivity and has been shown in animal models to regulate components of amyloid-beta metabolism [2] , a proposed key causative factor in AD. One recent study reported that the common Pro12Ala polymorphism of PPAR-γ was associated with increased risk of developing late-onset AD [3] , and another study provided evidence of a male-specific association between the Ala12 allele and late-onset dementia [4] . Other research suggests that type 2 diabetes (T2D) may modify the relationship between the Ala12 allele and cognitive decline [4, 5] .
This study aimed to examine the association between the Pro12Ala polymorphism of the PPAR-γ gene and performance on two tests of cognitive function at baseline and after follow-up in a population-based cohort study of older Hispanic and non-Hispanic white adults. Furthermore, we investigated whether these relationships were modified by sex, ethnicity or impaired glucose tolerance.
Methods

Study population
The study sample of 492 individuals was derived from the overlap between two population-based cohort studies: the San Luis Valley Diabetes Study (SLVDS) and the San Luis Valley Health and Aging Study (SLVHAS). The SLVDS, which originated in 1984 to study risk factors associated with T2D, collected blood samples for genetic analyses and classified glucose tolerance status among Hispanic and nonHispanic white residents from two rural counties in Southern Colorado. All surviving adults from the SLVDS populationbased sample, aged 60 years and older in 1993, were included in the SLVHAS where two measures of cognitive function were measured at study baseline and at one follow-up visit. Details of the sampling and recruitment for both studies have been described previously [6, 7] . The Colorado Multiple Institutional Review Board reviewed and approved each study. An approved informed consent was obtained from all participants. To be included in the present analysis, participants needed to have baseline and follow-up measures of cognitive function, genotyping and oral glucose tolerance test results.
Measurements
Cognitive and executive functions were assessed using two screening tools. The Mini Mental State Examination (MMSE) is a multi-domain cognitive screening tool with a score range of 0-30, with higher scores indicating better performance [8] . The Behavioral Dyscontrol Scale (BDS) is a measure of executive cognitive function with a score range of 0-9, with higher scores indicating better executive function [9] . Executive abilities involve relatively complex behaviour and include planning, active problem solving and anticipation of possible consequences of an intended course of action [10] . The BDS has been validated as a measure of voluntary control over behaviour, which is the fundamental executive cognitive ability [9, 11] .
Participants were administered the MMSE and BDS at SLVHAS baseline (between 1993 and 1995) , and again at a follow-up visit (between 1995 and 1997), an average of 22 months later. All interviews, including the cognitive tests, were administered in English or Spanish based on the participant's preference. The Spanish version of the MMSE was adapted from the Spanish version of the National Institute of Mental Health Diagnostic Interview Schedule [12] , and the exact wording of several questions was modified to account for the local dialect. A Spanish translation of the BDS was also available, and all interviewers were bilingual. In this population, more than 75% of Hispanics spoke and understood English fluently, and few interviews were completed entirely in Spanish. The interviews, which took place in the participant's home or in a community research clinic, collected participants' self-reported age, ethnicity and years of formal education.
DNA was extracted from whole-blood samples using the Pure Gene kit (Gentra Systems, Minneapolis, MN, USA) as well as a Qiagen kit (QIAGEN, Valencia, CA, USA). Genotyping for the Pro12Ala single-nucleotide polymorphism (rs1801282) of the PPAR-γ gene was performed using the GoldenGate assay (Illumina, San Diego, CA, USA) with a 96-sample array matrix and the BeadStudio software for analysis. Whole-genome amplification was performed for 22% of participants who had very low amounts of DNA using a REPLI-g ® Ultrafast MiniKit (100) (QIAGEN). The genomic sample success rate was 98% for the genomic samples and 95% for the amplified samples.
World Health Organization criteria were used to classify glucose tolerance by fasting plasma glucose concentration 2 hours after a 75 g glucose drink [13] . Participants were defined as having diabetes, impaired glucose tolerance or normal glucose tolerance. Weight and height, used to calculate body mass index (BMI), were measured at the baseline visit.
Genotyping for the ε4 allele of the apolipoprotein E (APOE) gene, a genetic variant shown to be consistently associated with increased risk for late-onset AD, was obtained in a large subset of our sample (79%) using an isoelectric focusing-immunoblotting method [14] and by a polymerase chain reaction protocol [15] .
Statistical analyses
Baseline MMSE and BDS scores were transformed to normalise their left-skewed distributions. The inverse of the reflected score added to a constant (1 / [(−1) score + constant]) was selected to maintain the original direction of the score and eliminate values of 0, while minimising the skewness of the transformed scores distribution. The constants used in the transformations were 34 for the MMSE and 22 for the BDS. Results from the regression models using transformed test scores were back-transformed using the equation: [constant -(1/least-squares mean estimate for Ala12 allele carrier status)]. The difference scores (baseline score minus follow-up score) followed relatively normal distributions and were not transformed.
Baseline and difference scores were assessed in separate multivariable linear regression models. Additional analyses were conducted to adjust for standard risk factors for cognitive decline including age, sex, ethnicity and education to increase the precision of the estimates. We further adjusted for APOE ε4 genotype, which was available for a large subset of the sample (n = 388). In the final model, we added BMI and glucose tolerance status, which are variables that may lie in the causal pathway between Ala12 carrier status and cognitive decline. Participant age, BMI and years of formal education were treated as continuous variables.
Interactions between genotype and sex, ethnicity and glucose tolerance status at baseline were tested by including product terms in the models. To determine the influence of ceiling and floor effects of both the MMSE and BDS on our results, we performed a sensitivity analysis, removing participants with both the lowest scores possible (0) and highest scores possible (19 for the BDS and 30 for the MMSE). Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
The frequency of the Ala12 allele was 13.1% within the study population; 12.4% among the Hispanic sample and 13.7% among the non-Hispanic white sample. These allelic frequencies are similar to other reports among Mexican American (10%) and Caucasian (12%) populations [16] . The study sample comprised 24.6% Ala12 allele carriers (1.6% Ala12Ala and 23.0% Pro12Ala) and 75.4% nonAla12 allele carriers (Pro12Pro). The genotype frequencies did not differ from the expected frequencies under HardyWeinberg equilibrium (P = 0.86).
The mean age at baseline of participants in this study was 70.6 years (range: 60-84 years) and did not differ significantly between the genotype groups ( Table 1) . Females were slightly more likely to carry the Ala12 allele than males. Years of education, ethnic composition of the sample, length of follow-up, prevalence of glucose impairment and BMI were not significantly different by genotype. At study baseline, 45% of the Hispanic sample had diabetes and 23% of the non-Hispanic white sample had diabetes.
For the baseline scores, there was no evidence of an interaction between genotype and sex, ethnicity or glucose impairment (P > 0.15 for each interaction). At baseline, presence of the Ala12 allele was not significantly associated with MMSE score (P = 0.62) nor with BDS score (P = 0.85). This lack of association persisted even after adjustment for age at baseline, sex, education, ethnicity, BMI and glucose tolerance status.
In the model of decline in MMSE score, the test of a three-way interaction term between genotype, sex and ethnicity yielded P = 0.04. Table 2 shows the estimated decline in MMSE score stratified by the cross-classification of sex and ethnicity. Decline was significantly greater among male Hispanic Ala12 carriers compared to male Hispanic noncarriers, and there was no attenuation of this estimate after covariate adjustment. The differences in decline by Ala12 carrier status among the other sex/ethnic groups did not reach statistical significance. There was no evidence of an interaction between the Pro12Ala genotype and glucose tolerance category (P = 0.54 for interaction term).
In the model of decline in BDS score, there was no evidence of an interaction by sex and/or ethnicity or glucose tolerance category between the Pro12Ala genotype and cognitive decline (P > 0.10 for each interaction). Although our investigation of the main effect of genotype on decline in BDS showed more decline in the BDS score among Ala12 carriers compared to non-carriers (1.0 versus 0.7 points), this difference did not reach statistical significance (P = 0.29).
Discussion
In this biethnic cohort of older adults, there were significantly greater declines in MMSE score among male Hispanic carriers of the Ala12 allele compared to male Hispanic non-carriers but not among the other sex/ethnic groups. These findings, related specifically to decline in MMSE scores but not BDS scores, suggest an association of the Ala12 allele with decline in global cognitive function. It is noteworthy that we observed a significantly higher rate of decline among Ala12 carriers compared to non-carriers over a relatively short duration of follow-up. For baseline cognitive test scores, there were no significant differences between Ala12 carriers and non-carriers. We did not observe evidence of modification of the association between the Ala12 allele and cognitive decline by glucose tolerance status. An increasing number of studies have reported a positive association between the Ala12 allele and risk of cognitive impairment. In support of our findings, a large cohort study of Mexican Americans reported a male-specific association between the Ala12 allele and late-onset cognitive impairment [4] . Another large case-control study reported a gender-specific difference in risk of late-onset AD such that there was a trend toward significance among males for the Ala12 to be a risk factor (odds ratio = 1.42, P = 0.08) [17] . Furthermore, Scacchi et al. reported that carrying the Ala12 allele significantly increased the risk of developing AD in individuals 80 years or older [3] . In a large biracial (blacks and whites) cohort, greater decline in cognitive performance was reported among non-Ala12 carriers but the results were attenuated after adjustment for race, suggesting a complex interrelationship among Pro12Ala, race/ethnicity and cognitive decline [18] .
Our data, combined with reports from previous studies, underscore the context-dependent association between the Pro12Ala polymorphism and cognitive decline and highlight the potential roles of ethnic background and gender influencing this complex interplay. Other male-restricted associations have been reported with the Pro12Ala polymorphism, particularly in relation to obesity susceptibility [19] [20] [21] . Gender-specific effects of genes involved in the regulation of lipid and glucose metabolism such as PPAR-γ could be attributed to hormonal differences, such as plasma oestrogens. Combining the substantial evidence that PPAR-γ is capable of adapting gene expression to integrate various lipid signals coming from the intracellular and extracellular environment [22] with the increasing evidence suggesting that a role for oestrogen in the regulation of adipose tissue and glucose [23] provides a potential biologic connection to the gender-specific results of our study. Although a phenotype resulting from a given genotype may vary between ethnic groups because of interactions with environmental and/or other genetic factors, we were unable to identify specific biologic mechanisms that may underlie the ethnicspecific observations in our study. Whether the Pro12Ala-gender interaction is a phenomenon across other ethnic populations will require additional study.
Although the biologic mechanisms that may underlie these observations are unclear, it has been demonstrated in animal studies that PPAR-γ activation promotes amyloid β clearance in the brain [2] . The substitution of alanine for proline in the Pro12Ala polymorphism also has been shown to moderately reduce transcriptional activity of PPAR-γ [24] . A reduction in transcription activity could potentially reduce amyloid β clearance and, as a consequence, increase amyloid β peptide deposition, which is a hallmark characteristic of AD.
This study had a number of strengths including the use of data from a population-based cohort followed longitudinally. The sensitivity analysis to assess the influence of floor and ceiling effects with the scales modestly increased the parameter estimates for both models of BDS score change and MMSE score change, giving additional credibility to our findings. Furthermore, we were able to investigate these associations among a Mexican American sample, an understudied population with a relatively high frequency of the Pro12Ala polymorphism [16] .
These findings are limited by the short follow-up of the cohort; longer follow-up would have allowed evaluation of the risk of Ala12 carrier status on longer-term cognitive decline. These findings are also limited by having only cognitive screening tests; full neuropsychological testing and clinical evaluation to diagnose dementia and determine different dementia subtypes were not available. Furthermore, because of the small numbers of the individuals who were homozygous for the Ala12 allele, we were unable to investigate a dose-response relationship. Finally, our findings are limited by the potential for type I error arising from multiple testing, particularly in the stratified analyses where decreased sample sizes make it more likely that heterogeneity could occur due to chance; as such, these findings require validation in an independent cohort.
Conclusions
Among older non-Hispanic white and Hispanic adults, carriers of the PPAR-γ Ala12 allele showed greater cognitive decline after 22 months of follow-up compared to non-carriers as detected by the MMSE, but the risk varied across sex and ethnic groups. Male Ala12 carriers of Hispanic origin may be a high-risk group for cognitive decline.
Key points
• Cognitive decline associated with Pro12Ala varied significantly across sex and ethnic groups.
• Male Ala12 carriers of Hispanic origin may be a high-risk group for cognitive decline.
• A significant difference in decline between Ala12 carriers and non-carriers was not observed among other sex/ethnic groups.
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